Timing of JAK initiation, shingles vaccine administration can affect outcomes in rheumatoid arthritis

For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to administration ...
HealthDay on MSN

Timing of JAK initiation, shingles vaccine administration can affect outcomes in RA

For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to administration ...
Medscape

JAK Inhibitors Linked to Higher Risk for Cancer Than TNF Inhibitors Across Immune-Mediated Inflammatory Diseases

JAK inhibitors are associated with a higher risk for malignancy than TNF inhibitors across immune-mediated inflammatory diseases, according to a meta-analysis.
Medscape

Timing of Initiating JAK Inhibitor May Affect but Not Prevent Zoster Vaccine Response in Rheumatoid Arthritis

Immediate initiation of JAK inhibitor therapy after recombinant zoster vaccination is linked to lower early immune responses than delayed initiation in patients with rheumatoid arthritis.
BroadwayWorld

Review: Jak Malone brings MISS YOU, MISS YOU, REALLY WANT TO KISS YOU to The Laurie Beechman Theatre

Jak Malone’s MISS YOU, MISS YOU, REALLY WANT TO KISS YOU is a love letter to New York, wrapped in smooth vocals, sparkle, and ...

Why Q32 Bio investors should take profits in the stock after 81% rally

Sell QTTB now. The Phase 2a headline is strong, but the stock is already up ~81% and nearly 6x YTD, with RSI in the ...
The Sixth Axis

Jak 4 – it’s finally time for a Jak & Daxter sequel

Despite lending their name to one of the best gaming trilogies, Jak & Daxter don’t enjoy the same all-star adoration as other PlayStation mascots. With the world still caught in an unfamiliar stasis, ...
Healio

JAK inhibitors ‘should be standard of care’ when treating alopecia

Please provide your email address to receive an email when new articles are posted on . Most people with alopecia are good candidates for JAK inhibitor therapy with proper counseling and monitoring.
MedPage Today

FDA Tweaks JAK Inhibitor Indication in Inflammatory Bowel Disease

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...
The American Journal of Managed Care

Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis

JAK inhibitors, a new class of tsDMARDs, have shown superior efficacy in RCTs for RA compared to other biologics. Real-world studies highlight JAK inhibitors' benefits in clinical disease activity, ...